DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fbrld9/competing_in_the) has announced the addition of the "Competing in the Global Contract Manufacturing Market: What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business" report to their offering.
The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 40-50% range across all product types, indicating opportunity for CMO vendor switching in the future. Of all parameters used in CMO agreements and selection, volume commitments ranks as the most important while capacity and site transfer ranks second. Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies which possess operations in the same region.
Market dynamics and CMO selection is as follows:
- Of the top CMOs, Baxter Biopharma Solutions, Boehringer Ingelheim, and Pfizer CentreSource are rated as having the highest degree of premium pricing which also correlates with these companies having the highest ranking for full service offerings or a broader number of services available.
- Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies that possess operations in the same region (i.e. European biotech companies are more likely to select European CMOs).
- Of all parameters used in CMO agreements and selection, volume commitments, ranks as the most important criterion, and capacity and site transfer ranks as second.
Criteria for business that is most or least likely to be outsourced to CMO companies:
- The most prevalent service capabilities being outsourced to CMO companies are packaging, logistics, and clinical trial supply.
- The most prevalent service capability being planned for outsourcing to CMO companies is drug delivery technology services.
- The least likely service capability to be considered for outsourcing is research and development - likely due to concerns regarding competitive intelligence and an inability to select and hire key staff.
Preferred CMO marketing exposure outlets are defined as follows:
- The most preferred methods for learning about CMO services are tradeshow and conference booths and word of mouth recommendations from colleagues.
- The top trade journal read is Pharmaceutical Outsourcing but other journals closely behind in ranking include Pharmaceutical Manufacturing, Contract Pharma, BioPharm International, and Pharmaceutical Technology.
- The top 2 trade shows attended or planned to be attended are BIO Annual Meeting and AAPS Annual Meeting.
- The top 2 e-newsletters read worldwide are Outsourcing Pharma and Fierce Biotech.
- Baxter Biopharma Solutions and Boehringer Ingelheim are the most preferred CMO companies, earning the largest share of preference.
- No single CMO company was able to achieve the highest preference across regions:
CMO prevalence by company and product type:
- Abbott is the most prevalently used company for basic oral solids due to its personnel background and expertise, indicating the high importance of a positive reputation.
- Baxter is the most prevalently used company for injectables due to their overall quality highlighting the importance of quality assurance for injectables which have the highest standards of quality.
- Abbott is the most prevalently used company for liquid dosage compounds, with the core reasons related to manufacturing capacity and personnel background and expertise.
- Catalent is the most prevalently used company for advanced oral solids, with overall quality being the core reason.
- No single company dominates mammalian product manufacturing, indicating opportunity for manufacturers with interest in the space.
- Lonza is the most prevalently used company for microbials, with overall quality being the core reason.
- Abbott is the prevalently used company for dermatological formulations, with the core reason related to overall quality.
- GlaxoSmithKline is the most prevalently used company for inhalation therapies, with overall quality and personnel background/expertise being the core reasons.
- GlaxoSmithKline and Sanofi are the most prevalently used for nasal sprays.
Key Topics Covered:
1. Research Objectives and Methodology
2. Executive Summary
3. An Overview of the Global Contract Manufacturing Market, Now and in the Future
4. Impact of Attitudes and Perceptions on CMO Outsourcing
5. Preferred CMOs and Drivers of Selection
6. The Outsourcing and Manufacturing Markets: Assessing Growth Opportunities and Threats
7. Areas of Marketing Opportunities
8. Appendices
For more information visit http://www.researchandmarkets.com/research/fbrld9/competing_in_the
